Stay updated on BevaciPembro Combo in EBER-ISH+ NPC Clinical Trial
Sign up to get notified when there's something new on the BevaciPembro Combo in EBER-ISH+ NPC Clinical Trial page.

Latest updates to the BevaciPembro Combo in EBER-ISH+ NPC Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check13 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check20 days agoChange DetectedThe page has been updated to version 2.16.0, with the removal of a detailed citation regarding the antitumor activity of Nivolumab in nasopharyngeal carcinoma.SummaryDifference6%
- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check56 days agoChange DetectedThe webpage has been updated to reflect a new version of the study protocol, including changes to the treatment arms and the addition of specific details about the study's eligibility criteria and collaborators.SummaryDifference52%
- Check63 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to BevaciPembro Combo in EBER-ISH+ NPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BevaciPembro Combo in EBER-ISH+ NPC Clinical Trial page.